Previous studies have demonstrated that NF-κB can facilitate the expression of key AD-related genes such as beta-site APP-cleaving enzyme 1 (BACE1) and amyloid precursor protein (APP) by binding to specific promoter regions [21,22,23]. Here, NFKB1 is linked to Alzheimer disease.